Key facts
- It has raised $21.2M; the latest was Accelerator/Incubator in May 2024.
- Notable investors include MedTech Innovator, National Development Fund of Taiwan, Ampoc Far-East Company, Top Taiwan Venture Capital Group, TransPacific Venture Partners — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Somnics
- ·The full record, as it builds
Funding rounds
No funding rounds for Somnics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Somnics
Developer of a sleep therapy system designed to offer support to patients suffering from sleep-disordered breathing. The company's main product iNAP is a sleep therapy system that utilizes oral negative pressure technology to treat obstructive sleep apnea patients, providing clients with a comfortable and discreet treatment for patients of Obstructive Sleep Apnea.
- Sector
- Healthcare
- HQ
- Zhubei, Taiwan
- Founded
- 2010
- Employees
- 48
- Website
- somnics.com/
- Ownership
- Privately Held (backing)
Somnics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Somnics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Somnics in its N-PORT filings yet. We sweep new filings monthly.